TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | 1 | -9 | -11 | -3 | 36 | 2 |
| P | %wins | 0 | 100 | 0 | 0 | 50 | 100 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/5/10 16:52 | 5/4/10 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | D | P | 50 | 38.40 | 33 | 1 | 100 | 3 | D | 46 | 26 | 15 | -5 | -9 | -4 | -1 | -3 | -2 | 1 | -5 | -6 | 1 | 45 | |
4/26/10 10:07 | 4/23/10 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | D | P | 50 | 38.60 | 33 | 1 | New | 1 | D | 49 | 46 | 18 | -3 | -11 | -5 | -3 | -4 | -1 | 0 | -12 | -15 | -7 | 27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |